• Foundation Events

  • Please Donate

  • Cancer Education

  • Community Outreach

Genetic Testing

If cancer runs in your family, you might want to consider genetic testing. If you would like to know more about your risk for inherited cancer, genetic testing can give you some answers by analyzing your genes for mutations responsible for inherited cancer risk. This information will make it easier for you to make decisions about what you can do for early cancer detection and risk reduction. If you have already been diagnosed with cancer, the genetic testing can still help you by providing information about the risk for a second cancer. Informing your family members, especially close relatives, is important if you have the inherited gene mutations. There is a chance that your parents, brothers and sisters or children might have these mutations, too, which increases their risk for cancer.

The Foundation provides testing for the following disorders:

  • Hereditary breast and ovarian cancer
  • Hereditary colorectal cancer
  • Hereditary Malignant melanoma

If you would like more information about genetic testing please e-mail to This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it. or call the Foundation at 281-558-1171.

Contact Us

  • Meet us
    12121 Richmond Ave
    Suite 107
    Houston, TX 77082
  • Call us
    281-558-1171
  • Write us
    This email address is being protected from spambots. You need JavaScript enabled to view it.

Upcoming Events

  • Cancer Support Group
    Please join us for our next Cancer Support Group. Lunch is provided.

    The group will be meeting in Suite 100 on the first floor at West Houston Medical Center, 12121 Richmond Ave, Houston, TX 77082.

    Read more.

Knowledge Corner

  • Promising Study Findings Pertaining to Aggressive Breast Cancer

    Using a chemotherapy treatment optimization strategy in high risk/metastatic breast cancer patients that included patients with triple negative disease resulted in low recurrence (8%), supporting potential curability in this breast cancer population. Read more.